Clinical Trial

Adjuvant Chemotherapy Combined With Targeted Therapy or Not in the T3-4N2 Colorectal Cancer Patients

Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial\] is to compare in resectable stage T3-4N2 colorectal cancer. The main question it aims to answer is: whether the use of targeted therapy in combination with adjuvant chemotherapy is associated with improved disease-free survival (DFS) compared to adjuvant chemotherapy alone.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-04-03.
Status change: Not Yet Recruiting → Recruiting 2023-05-22
Trial Details
NCT Number NCT05797467
Lead Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
Conditions Colorectal Cancer, Chemotherapy Effect
Enrollment 366 participants
Start Date 2023-04-01
Primary Completion 2030-04-01 (estimated)
Study Completion 2033-04-01 (estimated)
Updated on ClinicalTrials.gov 2023-05-24